Literature DB >> 21104447

Hepatic expression profile of forkhead transcription factor genes in normal Balb/c mice and their dynamic changes after bile duct ligation.

Ping Yang1, Shifeng Huang, Ding Liu, Qianyun Zhou, Yang-an Wen, Yu Xiang, Shan Sun, Xiaofei Lai, Yufang Dong, Liping Zhang.   

Abstract

Dysregulation of Forkhead box (Fox) transcription factor family genes was previously shown to lead to congenital disorders, diabetes mellitus, and carcinogenesis, and recent reports suggested that several Fox genes play important roles in the pathogenesis of liver fibrosis. The present study was initiated to determine the expression profiles of the Fox genes in normal Balb/c mouse liver and their dynamic expression changes during fibrogenesis induced by experimental bile duct ligation (BDL). RT-PCR was employed to detect 18 FOX family members including FOXO1, FOXO3, FOXM1, and FOXL1 in normal mouse liver. FQ-PCR was performed to analyze the dynamic mRNA expression changes of nine inflammation- or proliferation-related FOX family genes in BDL mice. Results showed that all the 18 Fox genes were expressed in the normal mouse liver, among which the expression of FOXO1 and FOXO3 were found to be the highest. The inflammation and proliferation-related FOX family genes were found to be dynamically changed during BDL-induced liver injury with reduced FOXO1 and enhanced FOXOL1 and FOXM1, indicating their potential involvement in the pathogenesis of liver fibrosis. This is the first systematic evaluation of hepatic expression of FOX genes in both normal and BDL mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104447     DOI: 10.1007/s11033-010-0408-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  11 in total

Review 1.  The Fox genes in the liver: from organogenesis to functional integration.

Authors:  John Le Lay; Klaus H Kaestner
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

2.  Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.

Authors:  Hiroshi Uchinami; Ekihiro Seki; David A Brenner; Jeanine D'Armiento
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

3.  Glucocorticoid pretreatment suppresses chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention.

Authors:  Chih-Sung Hsieh; Pei-Wen Wang; Shin-Ye Lee; Chao-Cheng Huang; Nyuk-Kong Chang; Ching-Mei Chen; Chia-Ling Wu; Hsiu-Chuan Wang; Jiin-Haur Chuang
Journal:  J Pediatr Surg       Date:  2006-10       Impact factor: 2.545

4.  The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells.

Authors:  Masayuki Adachi; Yosuke Osawa; Hiroshi Uchinami; Tadahiro Kitamura; Domenico Accili; David A Brenner
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

Review 5.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

Review 6.  Human FOX gene family (Review).

Authors:  Masuko Katoh; Masaru Katoh
Journal:  Int J Oncol       Date:  2004-11       Impact factor: 5.650

7.  Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

Authors:  Jing-Lin Xia; Chunsun Dai; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  The evolution of Fox genes and their role in development and disease.

Authors:  Sridhar Hannenhalli; Klaus H Kaestner
Journal:  Nat Rev Genet       Date:  2009-04       Impact factor: 53.242

9.  Enhanced glucose synthesis in three-dimensional hepatocyte collagen matrix.

Authors:  Yang-an Wen; Ding Liu; Yan-yu Xiao; Dan Luo; Yu-fang Dong; Li-ping Zhang
Journal:  Toxicol In Vitro       Date:  2009-03-05       Impact factor: 3.500

10.  Foxl1 is a marker of bipotential hepatic progenitor cells in mice.

Authors:  Sara D Sackett; Zhaodong Li; Reginald Hurtt; Yan Gao; Rebecca G Wells; Karrie Brondell; Klaus H Kaestner; Linda E Greenbaum
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.